-
Uncategorized2 months agoA criminal sentence for OxyContin maker Purdue Pharma clears the way for completing its settlement
A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the Justice Department on Tuesday, clearing the way for the company...
-
Uncategorized2 months ago
Replimune cuts will leave over 200 jobless in Massachusetts
Replimune is axing 144 employees at its Woburn headquarters and 80 at its Framingham manufacturing site. The cuts follow the FDA’s second rejection of the biotech’s...
-
Uncategorized2 months ago
Tortugas takes neuro deep dive with $106M to develop Eisai, Hansoh programs
With programs from Eisai and Hansoh Pharmaceutical in hand, Tortugas Neuroscience has emerged with hopes of delivering daily oral treatments to patients with central nervous system...
-
Uncategorized2 months agoSTAT+: Kelonia Therapeutics’ road from floundering to $3 billion
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Starting and sustaining...
-
Uncategorized2 months ago
Merck, Eisai’s Keytruda triplet fails to improve survival in kidney cancer
A triplet regimen comprising Merck’s Welireg and PD-1 blockbuster Keytruda and Eisai’s Lenvima flopped in a Phase 3 renal cell carcinoma trial.
-
Uncategorized2 months ago
AACR 2026: Moderna, Revolution, Zymeworks and BeOne showcase new data
Moderna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer.
-
Uncategorized2 months ago
Where Utah’s experiment with AI doctors is headed next
Companies looking to push the limits of artificial intelligence in healthcare are heading to Utah, where the state is giving them flexibility to use the technology...
-
Uncategorized2 months ago
Gilead, Arcus tumble again in TIGIT, triggering 2 trial culls
Gilead, Arcus tumble again in TIGIT, triggering 2 trial culls
-
Uncategorized2 months agoSTAT+: Kennedy hints at coming breakthrough device announcement
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your...
-
Uncategorized2 months ago
AACR 2026: A Video Update from San Diego
The American Association for Cancer Research (AACR) meeting is off and running in San Diego. Julianna LeMieux, PhD, Deputy Editor in Chief at GEN, and Damian...
SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines
